ブックタイトル血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

概要

血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

340. Balagtas RC, Bell CE, Edwards LD, Levin S. Risk of local and systemic infections associated with umbilicalvein catheterization: a prospective study in 86 newborn patients. Pediatrics 1971; 48:359?67.341. Butler-O’Hara M, Buzzard CJ, Reubens L, McDermott MP, DiGrazio W, D’Angio CT. A randomized trialcomparing long-term and short-term use of umbilical venous catheters in premature infants with birthweights of less than 1251 grams. Pediatrics 2006; 118:e25?35.342. Scheer B, Perel A, Pfeiffer UJ. Clinical review: complications and risk factors of peripheral arterial cathetersused for haemodynamic monitoring in anaesthesia and intensive care medicine. Crit Care 2002; 6:199?204.343. Lorente L, Santacreu R, Martin MM, Jimenez A, Mora ML. Arterial catheter-related infection of 2,949catheters. Crit Care 2006; 10:R83.344. Furfaro S, Gauthier M, Lacroix J, Nadeau D, Lafleur L, Mathews S. Arterial catheter-related infections inchildren. A 1-year cohort analysis. Am J Dis Child 1991; 145:1037?43.345. Rickard CM, Lipman J, Courtney M, Siversen R, Daley P. Routine changing of intravenous administrationsets does not reduce colonization or infection in central venous catheters. Infect Control Hosp Epidemiol2004; 25:650?5.346. Hanna HA, Raad I. Blood products: a significant risk factor for long-term catheter-related bloodstreaminfections in cancer patients. Infect Control Hosp Epidemiol 2001; 22:165?6.347. Saiman L, Ludington E, Dawson JD, et al. Risk factors for Candida species colonization of neonatalintensive care unit patients. Pediatr Infect Dis J 2001; 20:1119?24.348. Avila-Figueroa C, Goldmann DA, Richardson DK, Gray JE, Ferrari A, Freeman J. Intravenous lipidemulsions are the major determinant of coagulase-negative staphylococcal bacteremia in very low birthweight newborns. Pediatr Infect Dis J 1998; 17:10?7.349. Crocker KS, Noga R, Filibeck DJ, Krey SH, Markovic M, Steffee WP. Microbial growth comparisons of fivecommercial parenteral lipid emulsions. J Parenter Enteral Nutr 1984; 8:391?5.350. Jarvis WR, Highsmith AK. Bacterial growth and endotoxin production in lipid emulsion. J Clin Microbiol1984; 19:17?20.351. Karamanoglu A, Yumuk PF, Gumus M, et al. Port needles: do they need to be removed as frequently ininfusional chemotherapy? J Infus Nurs 2003; 26:239?42.352. Niel-Weise BS, Daha TJ, van den Broek PJ. Is there evidence for recommending needleless closedcatheter access systems in guidelines? A systematic review of randomized controlled trials. J Hosp Infect2006; 62:406?13.353. Inoue Y, Nezu R, Matsuda H, et al. Prevention of catheter-related sepsis during parenteral nutrition: effectof a new connection device. J Parenter Enteral Nutr 1992; 16:581?5.354. Yebenes JC, Vidaur L, Serra-Prat M, et al. Prevention of catheter-related bloodstream infection in criticallyill patients using a disinfectable, needle-free connector: a randomized controlled trial. Am J Infect Control2004; 32:291?5.355. Casey AL, Worthington T, Lambert PA, Quinn D, Faroqui MH, Elliott TS. A randomized, prospective clinicaltrial to assess the potential infection risk associated with the PosiFlow needleless connector. J Hosp Infect2003; 54:288?93.356. Esteve F, Pujol M, Limon E, et al. Bloodstream infection related to catheter connections: a prospective trialof two connection systems. J Hosp Infect 2007; 67:30?4.357. Yebenes JC, Delgado M, Sauca G, et al. Efficacy of three different valve systems of needle-free closedconnectors in avoiding access of microorganisms to endovascular catheters after incorrect handling. CritCare Med 2008; 36:2558?61.67